Navigation Links
GAP-AF study helps to define optimal approach to ablation
Date:6/25/2013

/p>

In the GAP-AF (AFNET1) study between February 2006 and August 2010, 233 patients with drug refractory paroxysmal AF were randomized to have either a complete procedure (n=117) or an incomplete procedure (n=116). For the incomplete procedure the EPs stopped the radiofrequency application at one site to permit reconduction from the circumference. The study, which was performed in seven German centres, was funded by the German Atrial Fibrillation Network (AFNET). The inclusion criteria for the study were that patients had to be aged over 55 years and to have been treated with one anti arrhythmic drug before they entered the trial. Patients with poor left ventricular function were excluded from the study.

The primary endpoint of the study was the time to first recurrence of symptomatic AF with duration of more than 30 seconds on trans-telephonic ECG monitoring, or detection of asymptomatic AF defined as two consecutive recordings of AF during a minimum of 72 hours. The study made use of the RhythmCard technology, a small credit card sized device that patients can place on their chest wall to record an ECG whenever they experienced symptoms of AF and transmit the data via the telephone. Additionally, patients were asked to record and transmit an ECG every day regardless of their symptoms.

Results showed that at the three month follow-up, sinus rhythm (normal beating of the heart) had been achieved in 37.8% (46)of patients who had complete ablation, versus 20.8% (26) with incomplete ablation (P<0.001). Furthermore, the mean number of days in sinus rhythm was 60 days for the complete group versus 16 days for the incomplete group (P<0.001).

At three months, when patients were taken back to the EP lab for a repeat investigation, 70 % of those randomised to complete PVI had gaps versus 89% randomised to incomplete PVI.

No significant differences were found for serious adverse events (including syncope, stroke, major bleeding, tam
'/>"/>

Contact: Jacqueline Partarrieu
press@escardio.org
33-622-418-492
European Society of Cardiology
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. New Study: Alcohol Drinkers May Face Long Term Health Issues
2. A Study Shows That Mom’s Obesity Surgery May Help Break Cycle in Obese Kids
3. New Study Casts Doubt on FDA Pradaxa Conclusions
4. Results of landmark 11-year study on weight losss effect on heart disease risks published today
5. Rottenstein Law Group LLP Acknowledges BMJ Study of Risks of Byetta, Januvia
6. JAAOS Study Exposes Importance of Child Safety Seats for Children between Four and Eight – Kiley Law Group, LLC
7. Renowned Hudson Valley ENT Sleep Specialist Selected to Participate in FDA Study of New Obstructive Sleep Apnea Treatment
8. SMU researcher receives Hogg Foundation grant to study childhood depression
9. Depression screening in AF Clinics recommended by study
10. Treating infection may have sting in the tail, parasite study shows
11. The Huntington Study Group announces first-HD study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... UWDress.com, one of the most famous dress ... of 2014 floor length bridesmaid dresses . Additionally, ... items. According to the company’s marketing specialist, all its ... rate (up to 60 percent off) before September 10. ... special neckline: strapless, one-shoulder, bateau and more. The main ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 According to new ... But Not Peer Pressure, Key to Prescription Drug Misuse Among ... primary focus for 18-29 year olds when it comes to ... the for this age group the real problem which influences ... drug associations and recreational use of them to have fun ...
(Date:8/29/2014)... Healthpointe is proud to welcome to ... will be practicing out of Healthpointe’s newest office directly ... Healthpointe’s orthopedic team, Dr. Rodas is board-certified ... in occupational medicine. , Among Dr. Rodas’ many ... of Raytheon, the world-class defense and aerospace company. Additionally, ...
(Date:8/29/2014)... regarded audiologist , Dr. Mary Ann Larkin has written 4 ... are titled:, , Revealing the Truth About Tinnitus ... The Top 5 Things You Should Know Before Buying a ... , Dr. Mary Anne Larkin choose to write about ... misinformation about each them. The reports are available for immediate ...
(Date:8/29/2014)... Healthpointe Medical Group, one of Southern California’s ... LAXMed. The medical center is less than 2 miles from ... the 405 freeway. , The LAX clinic marks the ... is located at: 8610 S. Sepulveda Blvd., Suite 204 Los ... LAX office will provide the same comprehensive services as Healthpointe’s ...
Breaking Medicine News(10 mins):Health News:2014 Floor Length Bridesmaid Dresses for Sale at UWDress.com 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 3Health News:Dr. Anthony G. Rodas Joins Healthpointe Team at LAX Office 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 3Health News:Healthpointe Obtains a New Medical Clinic in the LAX Area 2
... ... Pediatric Surgery , ... 16, 2009 -- Children,s National Medical Center today announced that it will create a new ... of Abu Dhabi. , , ,"This is a great day for Children,s National, but it,s ...
... , Pocono Medical Center and facilities ... of laboratory errors due to specimen mislabeling , ... northeast Pennsylvania have come together to reduce and eliminate laboratory errors ... effort when they noticed they were reporting a large number of ...
... FORT LAUDERDALE, Fla. and BEVERLY HILLS, Calif., Sept. 16 As ... for ways to supplement their income. In response, a new ... event at the Sofitel Hotel in Beverly Hills to introduce its ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090916/NY76803 ) , (Logo: ...
... , , , WASHINGTON, ... by U.S. Senate Finance Committee Chairman Max Baucus (D-MT) will ... health coverage, while letting insurance companies charge what they please ... the most successful insurance premium regulation law in the nation, ...
... , , ... Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced ... Trademark Office has issued a Notice of Allowance for Milestone,s ... Dynamic Pressure Sensing." , , ...
... ... CSL), one of the world,s leading manufacturers of influenza vaccine, announced that the U.S. ... licensure of its monovalent pandemic (H1N1) 2009 influenza A vaccine for active immunization of ... , ...
Cached Medicine News:Health News:New Surgery Institute at Children's National Medical Center Aims to Improve Surgery and Eliminate Pain 2Health News:New Surgery Institute at Children's National Medical Center Aims to Improve Surgery and Eliminate Pain 3Health News:New Surgery Institute at Children's National Medical Center Aims to Improve Surgery and Eliminate Pain 4Health News:Pennsylvania Patient Safety Authority Releases September Advisory 2Health News:Pennsylvania Patient Safety Authority Releases September Advisory 3Health News:Pennsylvania Patient Safety Authority Releases September Advisory 4Health News:Pennsylvania Patient Safety Authority Releases September Advisory 5Health News:livethesource(TM) Hosts Company Launch Event While Supporting The Brent Shapiro Foundation's Annual Sober Night Out 2Health News:livethesource(TM) Hosts Company Launch Event While Supporting The Brent Shapiro Foundation's Annual Sober Night Out 3Health News:Baucus Health Plan Won't Rein in Health Insurer Price Gouging of Middle Class; Consumer Watchdog Calls for 'Prior Approval' Rate Regulation in Health Reform 2Health News:Baucus Health Plan Won't Rein in Health Insurer Price Gouging of Middle Class; Consumer Watchdog Calls for 'Prior Approval' Rate Regulation in Health Reform 3Health News:Milestone Scientific Receives Notice of Allowance From U.S. Patent and Trademark Office 2Health News:Milestone Scientific Receives Notice of Allowance From U.S. Patent and Trademark Office 3Health News:Milestone Scientific Receives Notice of Allowance From U.S. Patent and Trademark Office 4Health News:CSL Biotherapies Announces FDA Marketing Approval of its Monovalent Pandemic (H1N1) 2009 Influenza A Vaccine 2
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... Disorders Drug Pipeline Insight 2014" report to their offering. ... in US is one of the largest segments of pharmaceuticals ... alarming rate, while the available therapies were unable to meet ... in the market for CNS disorder, especially over the past ...
(Date:8/29/2014)... 29, 2014 Research and Markets ... Development Trend Forecast of Pharmaceutical Equipment Market in China, ... Research and Development Trend Forecast of Pharmaceutical Equipment Market ... China,s pharmaceutical equipment industry in ... competition landscape, and business performance of domestic major enterprises, ...
(Date:8/29/2014)... , August 29, 2014 ... Market by Product & Services (Equipment, Reagent, Primer, ... Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, ... MarketsandMarkets, the global Oligonucleotide Synthesis Market is expected ... Million in 2014, growing at a CAGR of ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
... Company to present interim results from phase 2 trial of novel ... ... NEW HAVEN, Conn., April 3, 2008 Rib-X Pharmaceuticals,Inc. ("Rib-X" ... of novel antibiotics for the treatment of,antibiotic-resistant infections, today announced that ...
... Proof-of-Principle Studies -, GAITHERSBURG, Md., April 3, ... announced that it has signed an agreement,with Merck ... the use of the Iomai needle-free immunostimulant patch., ... exclusive license. These,preclinical proof-of-principle studies will be conducted ...
Cached Medicine Technology:Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference 2Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 2Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 3
... American Industrial Laboratories, Inc. specializes in ... eyebank and laboratory specular microscopes, digital ... camera digital upgrade package. Our software ... image data correlation with rapid image ...
... management software is a full-featured product ... clinical aspects of the ophthalmic practice. ... for the financial, administrative and clinical ... professional. Designed as a scaleable solution, ...
The ReSeeVit Slit Lamp System is an easy-to-use digital video imaging system that captures anterior segment and retinal images for documentation, diagnosis and patient education. The package includes...
... The 2V slit lamp ... slit lamp that is ... illumination tower and has ... magnification. Revolutionary design provides ...
Medicine Products: